Interferon Therapy of Multiple Sclerosis

Discover the groundbreaking insights in "Interferon Therapy of Multiple Sclerosis," a comprehensive reference authored by experts in the field and published by Taylor & Francis Inc in 1997. This substantial volume spans 570 pages, providing an in-depth exploration of the role of interferon (IFN) in managing multiple sclerosis (MS). Dive into cutting-edge research that covers a wide array of topics, from IFN-receptor molecular interactions to the synergy and interference of IFN with other therapeutic agents, including cytotoxic drugs and chemotherapy. The book also features detailed findings on IFN ß -1a (Avonex) and IFN -1b (Betaseron), making it an essential resource for clinicians and researchers alike. Enhance your understanding of MS treatment with this essential guide that bridges basic and clinical research.